Anna Solà

Anna Solà - Anna Solà - BIYSC
  • Associated Researcher in the Nephrology and Renal Transplantation Group (IDIBELL-Hospital de Bellvitge).
  • Co-foundator of a biotechnological spin-off, focused on cell therapy in regenerative medicine obtaining in 2017 the approval of the AEM for the Phase II Clinical Trial of the company’s first product.
  • Different international and national collaborations and actively participate in the European Commission in evaluations associated with the Marie Curie system since 2011.